checkAd
    Startseite > Aktien > Akero Therapeutics > Nachrichten
    Akero Therapeutics Aktie
    20,730
     
    USD
    -1,61 %
    -0,340 USD
    Letzter Kurs 02:00:00 Nasdaq
    20,700
     
    USD
    700 STK
    Geldkurs 16.05.24
    20,730
     
    USD
    3.100 STK
    Briefkurs 16.05.24
    ISIN: US00973Y1082 · WKN: A2PLNP · SYM: AKRO · USA

    Neueste Nachrichten

    Kirby McInerney LLP Reminds Akero Therapeutics, Inc. (AKRO) Investors of Class Action Filing and Encourages Investors to Contact the Firm
    14.05.24 · Business Wire (engl.) · Akero Therapeutics
    AKRO Stockholders with Large Losses Should Contact Robbins LLP for Information About the Class Action Against Akero Therapeutics, Inc.
    11.05.24 · Business Wire (engl.) · Akero Therapeutics
    Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Akero Therapeutics, Inc. (AKRO)
    10.05.24 · Business Wire (engl.) · Akero Therapeutics
    Akero Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
    10.05.24 · globenewswire · Akero Therapeutics
    Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Akero Therapeutics, Inc. (AKRO)
    09.05.24 · Business Wire (engl.) · Akero Therapeutics
    Akero Therapeutics to Present at the BofA Securities 2024 Health Care Conference
    08.05.24 · globenewswire · Akero Therapeutics
    Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Akero Therapeutics, Inc. (AKRO) Investors
    07.05.24 · Business Wire (engl.) · Akero Therapeutics
    The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Akero Therapeutics, Inc. (AKRO) Investors
    06.05.24 · Business Wire (engl.) · Akero Therapeutics
    INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Akero Therapeutics, Inc. (AKRO) Investors
    06.05.24 · Business Wire (engl.) · Akero Therapeutics
    Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Akero Therapeutics, Inc. (AKRO) on Behalf of Investors
    03.05.24 · Business Wire (engl.) · Akero Therapeutics
    Akero Therapeutics, Inc. (AKRO) Investor Notice: Robbins LLP Reminds Stockholders of the Akero Therapeutics, Inc. Class Action
    03.05.24 · Business Wire (engl.) · Akero Therapeutics
    INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Akero Therapeutics, Inc. (AKRO) on Behalf of Investors
    02.05.24 · Business Wire (engl.) · Akero Therapeutics